Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1991 4
1993 1
1995 2
1996 3
1997 2
1998 1
2000 1
2001 2
2004 4
2005 1
2006 1
2007 5
2008 8
2009 12
2010 12
2011 22
2012 13
2013 17
2014 16
2015 16
2016 13
2017 19
2018 30
2019 23
2020 17
2021 25
2022 19
Text availability
Article attribute
Article type
Publication date

Search Results

251 results
Results by year
Filters applied: . Clear all
Page 1
SJS/TEN 2019: From science to translation.
Chang WC, Abe R, Anderson P, Anderson W, Ardern-Jones MR, Beachkofsky TM, Bellón T, Biala AK, Bouchard C, Cavalleri GL, Chapman N, Chodosh J, Choi HK, Cibotti RR, Divito SJ, Dewar K, Dehaeck U, Etminan M, Forbes D, Fuchs E, Goldman JL, Holmes JH 4th, Hope EA, Hung SI, Hsieh CL, Iovieno A, Jagdeo J, Kim MK, Koelle DM, Lacouture ME, Le Pallec S, Lehloenya RJ, Lim R, Lowe A, McCawley J, McCawley J, Micheletti RG, Mockenhaupt M, Niemeyer K, Norcross MA, Oboh D, Olteanu C, Pasieka HB, Peter J, Pirmohamed M, Rieder M, Saeed HN, Shear NH, Shieh C, Straus S, Sukasem C, Sung C, Trubiano JA, Tsou SY, Ueta M, Volpi S, Wan C, Wang H, Wang ZQ, Weintraub J, Whale C, Wheatley LM, Whyte-Croasdaile S, Williams KB, Wright G, Yeung SN, Zhou L, Chung WH, Phillips EJ, Carleton BC. Chang WC, et al. Among authors: carleton bc. J Dermatol Sci. 2020 Apr;98(1):2-12. doi: 10.1016/j.jdermsci.2020.02.003. Epub 2020 Mar 7. J Dermatol Sci. 2020. PMID: 32192826 Free PMC article.
Does Ibuprofen Worsen COVID-19?
Moore N, Carleton B, Blin P, Bosco-Levy P, Droz C. Moore N, et al. Among authors: carleton b. Drug Saf. 2020 Jul;43(7):611-614. doi: 10.1007/s40264-020-00953-0. Drug Saf. 2020. PMID: 32529474 Free PMC article. No abstract available.
RARG variant predictive of doxorubicin-induced cardiotoxicity identifies a cardioprotective therapy.
Magdy T, Jiang Z, Jouni M, Fonoudi H, Lyra-Leite D, Jung G, Romero-Tejeda M, Kuo HH, Fetterman KA, Gharib M, Burmeister BT, Zhao M, Sapkota Y, Ross CJ, Carleton BC, Bernstein D, Burridge PW. Magdy T, et al. Among authors: carleton bc. Cell Stem Cell. 2021 Dec 2;28(12):2076-2089.e7. doi: 10.1016/j.stem.2021.08.006. Epub 2021 Sep 15. Cell Stem Cell. 2021. PMID: 34525346
Identification of Drug Transporter Genomic Variants and Inhibitors That Protect Against Doxorubicin-Induced Cardiotoxicity.
Magdy T, Jouni M, Kuo HH, Weddle CJ, Lyra-Leite D, Fonoudi H, Romero-Tejeda M, Gharib M, Javed H, Fajardo G, Ross CJD, Carleton BC, Bernstein D, Burridge PW. Magdy T, et al. Among authors: carleton bc. Circulation. 2022 Jan 25;145(4):279-294. doi: 10.1161/CIRCULATIONAHA.121.055801. Epub 2021 Dec 7. Circulation. 2022. PMID: 34874743
Gene-based warfaring dosing.
Carleton B. Carleton B. Ther Drug Monit. 2010 Jun;32(3):332. doi: 10.1097/FTD.0b013e3181e1a665. Ther Drug Monit. 2010. PMID: 20498559 No abstract available.
Reducing anthracycline-induced cardiotoxicity through pharmacogenetics.
Scott E, Hasbullah JS, Ross CJ, Carleton BC. Scott E, et al. Among authors: carleton bc. Pharmacogenomics. 2018 Oct;19(15):1147-1150. doi: 10.2217/pgs-2018-0124. Epub 2018 Sep 14. Pharmacogenomics. 2018. PMID: 30213233 Free article. No abstract available.
Predictive genotype.
Ito S, Carleton BC. Ito S, et al. Among authors: carleton bc. CMAJ. 2010 May 18;182(8):804. doi: 10.1503/cmaj.110-2061. CMAJ. 2010. PMID: 20479057 Free PMC article. No abstract available.
Prevention of adverse drug effects: a pharmacogenomic approach.
Scott EN, Hasbullah JS, Carleton BC, Ross CJD. Scott EN, et al. Among authors: carleton bc. Curr Opin Pediatr. 2020 Oct;32(5):646-653. doi: 10.1097/MOP.0000000000000935. Curr Opin Pediatr. 2020. PMID: 32796162 Review.
251 results